What analysts say:
- Buy, sell, or hold?: The majority of analysts back Altera as a buy. But with 60.9% of analysts rating it a buy, Altera is still below the mean analyst rating of its nearest 10 competitors, which average 64.3% buys. Analysts like Altera better than competitor Xilinx overall. Nine out of 21 analysts rate Xilinx a buy compared with 14 of 23 for Altera. Analysts still rate the stock a moderate buy, but they are a bit more wary about it compared with three months ago.
- Revenue Forecasts: On average, analysts predict $542.2 million in revenue this quarter. That would represent a rise of 2.8% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.59 per share. Estimates range from $0.58 to $0.64.
What our community says:
CAPS All-Stars are solidly backing the stock with 96.4% assigning it an "outperform" rating. The community at large backs the All-Stars with 92.8% giving it a rating of "outperform." Fools are keen on Altera and haven't been shy with their opinions lately, logging 119 posts in the past 30 days. Even with a robust four out of five stars, Altera's CAPS rating falls a little short of the community's upbeat outlook.
Altera's profit has risen year over year by an average of more than twofold over the past five quarters.
For all our Altera-specific analysis, including earnings and beyond, add Altera to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.